Curaleaf Completes Acquisition of Alternative Therapies Group's Cultivation and Processing Operations

WAKEFIELD, Mass., Nov. 5, 2020 /CNW/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, today announced the successful completion of the Company’s acquisition of Alternative Therapies Group’s (“ATG”) licensed cultivation and processing operations in Amesbury, Massachusetts as of November 3, 2020.

Joseph Lusardi, Chief Executive Officer of Curaleaf, stated, “With the acquisition of ATG’s grow and processing operations, we’ll be adding 53,600 square feet of capacity to our existing 104,000 square feet capacity in Massachusetts. The Amesbury facility is fully built out, operational, and will be immediately accretive to our production capabilities in Massachusetts, which, according to Cannabis Benchmarks, currently commands the second highest wholesale flower prices in the nation.”

Combined with Curaleaf’s current cultivation facility in Webster, Massachusetts, the ATG acquisition brings Curaleaf’s total cultivation capacity in the state to 157,600 square feet. The integration of the new operations establish Curaleaf as the only cannabis provider in Massachusetts approved for two adult-use cultivation licenses, two adult-use processing licenses, and the maximum-permitted three adult-use dispensary licenses. In connection with the acquisition, ATG’s dispensaries located in Amesbury, Salisbury and Salem have been spun off and continue to

Read More

 

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Scroll to Top